Aucta has gained support from a dedicated group of investors including both global and China-based healthcare funds: Advantech, Cowin Venture, Sangel, and Grand Yangtze Capital.

Our investors are committed to supporting Aucta in becoming a significant specialty pharma player in both the United States and China.